Back
Prognosis and Evolution of Lassa Virus Infected Persons during the 2017 Epidemic in Togo
Majesté Ihou Wateba, Lidawou Bawé, Sika Dossim
Adv. Infect. Dis. Vol.8 No.4, December 20, 2018  DOI: 10.4236/aid.2018.84022
       (PDF  268K)     HTML      XML
Antiretroviral Therapeutic Profile in Patients Living with HIV with Chronic Kidney Disease
Yawovi Mawufemo Tsevi, Lidaw Déassoua Bawe, Komi Dzidzonu Nemi, Abdou Razak Moukaila, Akessiwe Akouda Patassi, Majesté Ihou Majesté Ihou
Adv. Infect. Dis. Vol.9 No.3, September 12, 2019  DOI: 10.4236/aid.2019.93019
       (PDF  355K)     HTML      XML
Cryptococcal Meningitis of the HIV-Infected Person in Lomé: About 102 Cases over 10 Years
Ihou Majesté Wateba, Abago Balaka, Alain Lidaw Bawe, Awereou Kotosso
World J. AIDS Vol.7 No.3, September 19, 2017  DOI: 10.4236/wja.2017.73017
       (PDF  223K)     HTML      XML
The Lassa Virus Epidemic in Mango, Togo: Therapeutic Route of the First 4 Cases
Majesté Ihou Wateba, Aimé Dakévi, Lidawu Bawé, Abago Balaka, Awereou Kotosso
Adv. Infect. Dis. Vol.7 No.4, November 17, 2017  DOI: 10.4236/aid.2017.74014
       (PDF  212K)     HTML      XML
Viral Characteristic of HIV Infected Patients Naïf of Anti-Retroviral Therapy with CD4+ T Lymphocytes Rate Greater than 350 per Microliter of Blood in Lomé Togo
Ihou Nazoba Majesté Wateba, Akouda Akessiwe Patassi, Abago Balaka, Ousséni Tidjani
World J. AIDS Vol.3 No.4, December 27, 2013  DOI: 10.4236/wja.2013.34047
       (PDF  122K)     HTML     
 
 
Top